A Systematic Review to Evaluate Patient-Reported Outcome Measures Methodology

Metastatic prostate cancer (mPCa) is one of the most common solid tumors in men and both the disease and the treatments affect patients’ quality of life (QoL). Patient-reported Outcome Measurements (PROMs) are important to assess the patient’s subjective experience with disease and treatment. Our ai...

Full description

Saved in:
Bibliographic Details
Published in:Cancers 2022, Vol.14 (20)
Main Authors: Ratti, Maria Monica, Gandaglia, Giorgio, Sisca, Elena Silvia, Derevianko, Alexandra, Alleva, Eugenia, Beyer, Katharina, Moss, Charlotte, Barletta, Francesco, Scuderi, Simone, Omar, Muhammad Imran, MacLennan, Steven, Williamson, Paula R, Zong, Jihong, MacLennan, Sara J, Mottet, Nicolas, Cornford, Philip, Aiyegbusi, Olalekan Lee, Van Hemelrijck, Mieke, N’Dow, James, Briganti, Alberto
Format: Report
Language:English
Subjects:
Care and treatment
Metastasis
Patient outcomes
Prostate cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Metastatic prostate cancer (mPCa) is one of the most common solid tumors in men and both the disease and the treatments affect patients’ quality of life (QoL). Patient-reported Outcome Measurements (PROMs) are important to assess the patient’s subjective experience with disease and treatment. Our aim is to appraise, compare, and summarize the psychometric properties of Patient-reported Outcome Measures (PROMs). Our findings can improve patients’ care and their quality of life during treatment and the disease path.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers14205120